Molecular basis of colorectal cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.Molecular diagnosis & therapy · 2022
   Pooled it
2. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.International journal of molecular sciences · 2021
   Article
3. [miR-593 inhibits proliferation of colon cancer cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
   Article
4. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.Cancer biomarkers : section A of Disease markers · 2019
   Article
5. Elevated G-Protein Receptor 125 (GPR125) Expression Predicts Good Outcomes in Colorectal Cancer and Inhibits Wnt/β-Catenin Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2018
   Article
6. Exploration of the mechanism of colorectal cancer metastasis using microarray analysis.Oncology letters · 2017
   Article
7. Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.BioMed research international · 2016
   Review
8. Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer.Clinical epigenetics · 2014
   Article
9. Targeted therapies for hepatocellular carcinoma.Gastroenterology · 2011
   Review

Corrections and comments

• Comment on
  Molecular origins of cancer: Molecular basis of colorectal cancer.2009

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as